A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Takeda
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute
University Hospital, Brest
Incyte Corporation
Constellation Pharmaceuticals
Chengdu Zenitar Biomedical Technology Co., Ltd
Centre Hospitalier Universitaire, Amiens
Ohio State University Comprehensive Cancer Center
PharmaEssentia Japan K.K.
Incyte Corporation
Celgene
Massachusetts General Hospital
Janssen Research & Development, LLC
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
University Hospital, Angers
M.D. Anderson Cancer Center
PharmaEssentia Japan K.K.
Advice Pharma Group srl
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
St. Petersburg State Pavlov Medical University
Ottawa Hospital Research Institute
St. Petersburg State Pavlov Medical University
Ipsen
City of Hope Medical Center
Stanford University
Washington University School of Medicine
University of Nebraska
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
University Health Network, Toronto
Herlev Hospital
University of Washington
Eastern Cooperative Oncology Group
Rutgers, The State University of New Jersey
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
University of California, San Francisco
Medical College of Wisconsin
University of Virginia